Journal profile · Medicine-Endocrinology, Diabetes and Metabolism
Diabetes/Metabolism Research and Reviews
ISSN 1520-7560 · Wiley-Blackwell · United States
Diabetes/Metabolism Research and Reviews: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 8.13; hybrid open access; APC about USD 4,780; median 126 days to acceptance (93 articles, last 24 months); acceptance rate 7% (journal website); 108 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diabetes/Metabolism Research and Reviews is published by Wiley-Blackwell and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes and associated disorders, Diabetes Management and Research and Pancreatic function and diabetes, together about 32.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Diabetes/Metabolism Research and Reviews is an indispensable resource for clinicians and researchers working in the fields of diabetes, endocrinology, metabolism and obesity. Our reviews section provides the latest updates on clinical and basic scientific advances in key areas of diabetes, obesity and metabolism, important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians. Original articles describing clinical studies, translational and basic research related to diabetes, obesity, metabolism, or closely related metabolic disorders are welcome, as are articles concerned with treatment and management issues related to patient care. Please note that Diabetes/Metabolism Research and Reviews is an online-only journal. Benefits for our authors: - No charges for colour figures - Accepted article PDFs are published within days of acceptance - Faster issue publication times for full final articles - Better integration of online supporting information for articles Diabetes/Metabolism Research and Reviews publishes supplements. If you are interested in publishing a supplement, please visit our Contact page and select your region in the Advertising and Corporate Sales section.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Endocrinology, Diabetes and Metabolism
Editor-in-chief Paolo PozzilliPublisher website
Editorial board by country: 2 in mainland China (about 50%); most named Mainland China 2, United Kingdom 1, Italy 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology11.7%
- Diabetes Management and ResearchMedicine11.1%
- Pancreatic function and diabetesMedicine10%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine9.2%
- Diabetes Treatment and ManagementMedicine7.8%
- Diabetic Foot Ulcer Assessment and ManagementMedicine5.8%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.2%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.13LetPub ·
- Impact factor (publisher) 2025
- 8.3Publisher website ·
- CiteScore 2026-06
- 13.4LetPub ·
- CiteScore (publisher) 2025
- 13.4Publisher website ·
- SJR 2026-06
- 2.03LetPub ·
- SNIP 2026-06
- 2.5LetPub ·
- h-index
- 161OpenAlex ·
- i10-index
- 2,036OpenAlex ·
- 2-year mean citedness
- 5OpenAlex ·
- Self-citation rate
- 1.2%LetPub ·
- Share of gold OA articles
- 49.68%LetPub ·
Volume
- Articles per year
- 86LetPub ·
- Articles per year (publisher) 2025
- 91Publisher website ·
- Downloads per year (publisher) 2025
- 706,705Publisher website ·
Articles by year OpenAlex count · 3,427 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 120 | 76 | 70 |
| 2025 | 108 | 84 | 478 |
| 2024 | 118 | 79 | 1,182 |
| 2023 | 159 | 119 | 4,532 |
| 2022 | 99 | 38 | 1,469 |
| 2021 | 92 | 37 | 2,725 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
126 daysMedian, submission to acceptance · P25–P75 88 days – 196 days
- Acceptance to online
- median 16 days (93 articles)
- Submission to online
- median 147 days
- Sample
- 93 articles with submission and acceptance dates (245 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher) 2025
- 7%Publisher website ·
- Submission to first decision 2025
- 3 daysPublisher website ·
- Submission to acceptance 2025
- 169 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,780 / EUR 3,980 / GBP 3,130 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≤ 6
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
Article types accepted4, with length limits
- commentariesCommentaries: Commentaries cover a variety of topics of current interest. The Journal welcomes submissions and proposals.Length not stated
- commentarynal welcomes submissions and proposals. Commentaries are generally limited to 1,500 words and 15 references. No abstract is required for a commentarymain text ≤ 1,500 words
- research articlesResearch articles should be structured as follows: Title page: Author names, affiliations (including complete Institution Name, Country, Department Name, Instit…Length not stated
- review articlesReview articles: Reviews are typically invited, but authors are welcome to contact the Editorial office with proposals for potential reviews.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a Data Availability Statement, including a link to the repository they have used, in the intial submission in order that this statement can be published alongside their paper. More information and templates of Data Avai…
Source ↗Publisher website ·- Publication ethics Publication Ethics
COPE membership Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Peer review type Model summary
The acceptance criteria for all papers is the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Wiley's policy on confidentiality of the review process i…
Source ↗Publisher website ·- Plagiarism
Plagiarism screening Model summary
This journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
Source ↗Publisher website ·- Preprints Preprint Policy
Preprint policy Model summary
Diabetes/Metabolism Research and Reviews will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- United States
- Language
- English
- ISSN
- 1520-7560
- Latest issue on the website
- Volume 42, Issue 6 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Diabetes/Metabolism Research and Reviews
What CAS zone is Diabetes/Metabolism Research and Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetes/Metabolism Research and Reviews is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetes/Metabolism Research and Reviews?
The latest impact factor listed by LetPub is 8.13; CiteScore 13.4, h-index 161.
How long does peer review take at Diabetes/Metabolism Research and Reviews?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 88–196 days); the journal's website gives an acceptance rate of 7% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Diabetes/Metabolism Research and Reviews?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≤ 6; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Diabetes/Metabolism Research and Reviews based?
Of the 4 board members whose country the journal's board page names, 2 (about 50%) are in mainland China; the countries named most often are Mainland China (2), United Kingdom (1) and Italy (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Diabetes/Metabolism Research and Reviews?
According to LetPub and DOAJ records, Diabetes/Metabolism Research and Reviews is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Diabetes/Metabolism Research and Reviews open access, and what is the APC?
Diabetes/Metabolism Research and Reviews is a hybrid journal. For open-access publication: APC about USD 4,780.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .